Cigna Group $CI Shares Purchased by Heritage Investors Management Corp

Heritage Investors Management Corp raised its position in Cigna Group (NYSE:CI) by 24.8% in the fourth quarter, Holdings Channel reports. The fund owned 17,243 shares of the health services provider’s stock after buying an additional 3,429 shares during the period. Heritage Investors Management Corp’s holdings in Cigna Group were worth $4,746,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after acquiring an additional 4,738 shares during the last quarter. Maj Invest Holding A S lifted its stake in Cigna Group by 2.4% in the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after acquiring an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC lifted its stake in Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after acquiring an additional 7,748 shares during the last quarter. National Pension Service lifted its stake in Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after acquiring an additional 21,203 shares during the last quarter. Finally, Caprock Group LLC purchased a new position in Cigna Group in the third quarter worth approximately $4,124,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 205,904 shares of company stock worth $60,277,068 in the last 90 days. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages recently issued reports on CI. TD Cowen lifted their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday. Leerink Partners boosted their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Finally, UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $338.55.

Cigna Group Stock Down 0.4%

Shares of NYSE:CI opened at $281.84 on Friday. The company has a market capitalization of $74.56 billion, a PE ratio of 11.95, a P/E/G ratio of 0.99 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The firm has a 50 day simple moving average of $276.12 and a 200-day simple moving average of $276.03.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.